Access to cancer care for Medicaid patients at cancer hospitals in the United States.

Authors

null

Victoria A. Marks

Yale School of Medicine, New Haven, CT

Victoria A. Marks , Walter R. Hsiang , James Nie , Matthew Buck , Patrick C Demkowicz , Waez Umer , Afash Haleem , Bayan Galal , Irene Pak , Dana Kim , Patrick Aloysius Kenney , Michael S. Leapman

Organizations

Yale School of Medicine, New Haven, CT, Department of Urology, Yale School of Medicine, New Haven, CT, The College of New Jersey, Ewing, NJ, Yale University, New Haven, CT

Research Funding

No funding received
None

Background: As the result of expansions associated with the Affordable Care Act (ACA), one in five Americans are now insured through Medicaid. Despite overall increases, access to care for Medicaid-insured patients with cancer may be limited by facilities due to lower reimbursement and administrative burden. We aimed to directly assess facility-level acceptance of Medicaid patients with a new diagnosis of cancer. Methods: We performed a cross-sectional secret shopper study to evaluate access to cancer care for colorectal, breast, urologic, and skin cancer at Commission on Cancer (CoC) accredited hospitals. We studied the relationship between Medicaid access and facility-level characteristics assessed through American Hospital Association and Center for Medicare and Medicaid Service data using univariable statistics and multivariable logistic regression. Results: Among 334 CoC facilities contacted, the overall rate of Medicaid acceptance for at least one investigated cancer type was 99% (n = 331). However, we identified hospital-level variation in Medicaid acceptance across cancer types, where Medicaid acceptance for colorectal, breast, urologic, and skin cancer was 90%, 96%, 87%, and 80%, respectively. Of the hospitals that accepted Medicaid, 2% accepted Medicaid for one cancer type, 8% for two, 21% for three, and 68% for all four cancer types. In multivariable logistic regression, odds of Medicaid acceptance were lowest in comprehensive community cancer centers (p < 0.05 for colorectal and urologic cancer) and for-profit designated facilities (p < 0.05 for urologic and skin cancer) (Table). Hospitals in states with Medicaid expansion were also more likely to accept Medicaid for urologic (OR: 2.5, 95% CI: 1.2-5.2) and breast (OR: 12.8, 95% CI: 2.7-60.2) cancer care. Conclusions: Access disparities persist for patients with Medicaid, with acceptance rates differing substantially within and between facilities. Facility-level differences in Medicaid access among CoC facilities are notable given the use of hospital registry data to estimate ACA-related effects.

Hospital Characteristic
Colorectal
OR (95% CI)
Urologic
OR (95% CI)
Breasta
OR (95% CI)
Skin
OR (95% CI)
Facility Type
Community (n = 75)
Ref
Ref
Ref
Ref

NCI Designated (n = 29)
0.2 (0.0, 2.2)
0.4 (0.0, 4.1)
-
1

Integrated Network (n = 36)
0.4 (0.0, 3.2)
0.6 (0.1, 2.8)
-
0.5 (0.1, 2.0)

Academic Comprehensive (n = 44)
0.8 (0.1, 10.2)
0.8 (0.1, 6.5)
-
0.9 (0.2, 5.1)

Comprehensive Community (n = 150)
0.2, (0.0, 0.8)*
0.27 (0.1, 0.8)*
-
0.4 (0.2, 1.0)
Ownership
Government (n = 39)
Ref
Ref
Ref
Ref

For-profit (n = 38)
0.6 (0.1, 4.3)
0.1 (0.0, 1.0)*
-
0.1, (0.0, 0.7)*

Nongovernment, Not-for-profit (n = 257)
0.9 (0.2, 4.1)
0.2 (0.0, 1.7)
-
0.4 (0.1, 1.6)

a Association between facility type and Medicaid acceptance for breast cancer care did not approach significance (p < 0.1) on univariable analysis and was not included in the multivariable model. *p < 0.05

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Access to Care

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 6548)

DOI

10.1200/JCO.2021.39.15_suppl.6548

Abstract #

6548

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

Abstract

2021 ASCO Annual Meeting

Accessibility of Telehealth services for cancer care at cancer hospital in the United States.

First Author: Victoria A. Marks

First Author: Dhaval Patel

First Author: Matthew Buck

First Author: Joseph M. Unger